Medicinal attributes of pyrazolo[3,4-d]pyrimidines: A review

被引:158
作者
Chauhan, Monika [1 ]
Kumar, Raj [1 ]
机构
[1] Cent Univ Punjab, Lab Drug Design & Synth, Ctr Chem & Pharmaceut Sci, Sch Basic & Appl Sci, Bathinda 151001, India
关键词
Pyrazolo[3,4-d]pyrimidine; Activities; SAR; IC50; MICROWAVE-ASSISTED SYNTHESIS; SRC KINASE INHIBITORS; ONE-POT SYNTHESIS; ANTIMICROBIAL ACTIVITY; PYRAZOLO<3,4-D>PYRIMIDINE RIBONUCLEOSIDES; BIOLOGICAL-ACTIVITY; IN-VITRO; ALLOPURINOL RIBONUCLEOSIDE; CGMP PHOSPHODIESTERASE; PYRAZOLOPYRIMIDINE;
D O I
10.1016/j.bmc.2013.07.027
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
070307 [化学生物学]; 071010 [生物化学与分子生物学];
摘要
Pyrazolopyrimidines are the fused heterocyclic ring systems which structurally resemble purines which prompted biological investigations to assess their potential therapeutic significance. They are known to play a crucial role in numerous disease conditions. The advent of their first bioactivity as adenosine antagonistic property divulged their medicinal potential. Radioactivity test on mice cells, morphometric and serological tests on rat hepatocytes, antitumor testing against L1210 and P388 leukemias in mice threw light on their biophysical aspects of significance. Biochemical properties were explored via xanthine oxidase assay, antioxidant enzyme assays, Western blot analysis, mRNA expression of apoptopic genes, receptor binding assays, and tryptan blue exclusion cytotoxicity evaluation. The collective results of biochemical and biophysical properties foregrounded their medicinal significance in central nervous system, cardiovascular system, cancer, inflammation etc. The present manuscript to the best of our knowledge is the first compilation on synthesis and medicinal aspects including structure-activity relationships of pyrazolo[3,4-d]pyrimidines reported to date. (C) 2013 Elsevier Ltd. All rights reserved.
引用
收藏
页码:5657 / 5668
页数:12
相关论文
共 105 条
[1]
Synthesis and antimicrobial activity of some new pyrazole, fused pyrazolo[3,4-d]-pyrimidine and pyrazolo[4,3-e][1,2,4]triazolo[1,5-c] pyrimidine derivatives [J].
Abunada, Nada M. ;
Hassaneen, Hamdi M. ;
Kandile, Nadia G. ;
Miqdad, Omar A. .
MOLECULES, 2008, 13 (07) :1501-1517
[2]
Novel pyrazolo[3,4-d]pyrimidine-based inhibitors of Staphlococcus aureus DNA polymerase III:: Design, synthesis, and biological evaluation [J].
Ali, A ;
Taylor, GE ;
Ellsworth, K ;
Harris, G ;
Painter, R ;
Silver, LL ;
Young, K .
JOURNAL OF MEDICINAL CHEMISTRY, 2003, 46 (10) :1824-1830
[3]
Synthesis and SAR of a new series of COX-2-selective inhibitors:: Pyrazolo[1,5-α]pyrimidines [J].
Almansa, C ;
de Arriba, AF ;
Cavalcanti, FL ;
Gómez, LA ;
Miralles, A ;
Merlos, M ;
García-Rafanell, J ;
Forn, J .
JOURNAL OF MEDICINAL CHEMISTRY, 2001, 44 (03) :350-361
[4]
Amir M., 2007, Indian Journal of Pharmaceutical Sciences, V69, P337
[5]
SYNTHESIS OF CERTAIN PYRAZOLO[3,4-D]PYRIMIDIN-3-ONE NUCLEOSIDES [J].
ANDERSON, JD ;
COTTAM, HB ;
LARSON, SB ;
NORD, LD ;
REVANKAR, GR ;
ROBINS, RK .
JOURNAL OF HETEROCYCLIC CHEMISTRY, 1990, 27 (02) :439-453
[6]
Pyrazolo[3,4-d]pyrimidines c-Src inhibitors reduce epidermal growth factor-induced migration in prostate cancer cells [J].
Angelucci, Adriano ;
Schenone, Silvia ;
Gravina, Giovanni Luca ;
Muzi, Paola ;
Festuccia, Claudio ;
Vicentini, Carlo ;
Botta, Maurizio ;
Bologna, Mauro .
EUROPEAN JOURNAL OF CANCER, 2006, 42 (16) :2838-2845
[7]
ACTION OF PYRAZOLOPYRIMIDINE DERIVATIVES ON AMERICAN LEISHMANIA SPP PROMASTIGOTES [J].
AVILA, JL ;
POLEGRE, MA ;
AVILA, A ;
ROBINS, RK .
COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY C-PHARMACOLOGY TOXICOLOGY & ENDOCRINOLOGY, 1986, 83 (02) :285-289
[8]
Molecular iodine promoted synthesis of new pyrazolo[3,4-d]pyrimidine derivatives as potential antibacterial agents [J].
Bakavoli, Mehdi ;
Bagherzadeh, Ghodsieh ;
Vaseghifar, Maryam ;
Shiri, Ali ;
Pordel, Mehdi ;
Mashreghi, Mansour ;
Pordeli, Parvaneh ;
Araghi, Maryam .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2010, 45 (02) :647-650
[9]
Baviskar A. T., 2013, BIOORGAN MED CHEM, DOI DOI 10.1016/JIMC.2013.07.016
[10]
Beer B., 1997, CNS Drug Reviews, P207, DOI [10.1111/j.1527-3458.1997.tb00324.x, DOI 10.1111/J.1527-3458.1997.TB00324.X]